![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:1317667 | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of BTF3 mRNA | CTD | PMID:22079256 | (S)-nicotine | decreases expression | ISO | RGD:1317667 | 6480464 | Nicotine results in decreased expression of BTF3 mRNA | CTD | PMID:18247414 | 1,2-dimethylhydrazine | decreases expression | ISO | RGD:1317668 | 6480464 | 1, 2-Dimethylhydrazine results in decreased expression of BTF3 mRNA | CTD | PMID:22206623 | 1,2-dimethylhydrazine | multiple interactions | ISO | RGD:1317668 | 6480464 | [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of BTF3 mRNA | CTD | PMID:22206623 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1317668 | 6480464 | Tetrachlorodibenzodioxin affects the expression of BTF3 mRNA | CTD | PMID:20702594, PMID:21570461 | 2,3,7,8-Tetrachlorodibenzofuran | affects expression | ISO | RGD:1317668 | 6480464 | 2 more ... | CTD | PMID:20702594 | 2,4-dibromophenyl 2,4,5-tribromophenyl ether | decreases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:19954255 | 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2, 4-dinitrotoluene affects the expression of BTF3 mRNA | CTD | PMID:21346803 | 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2, 6-dinitrotoluene affects the expression of BTF3 mRNA | CTD | PMID:21346803 | 2-hydroxypropanoic acid | increases expression | ISO | RGD:1317667 | 6480464 | Lactic Acid results in increased expression of BTF3 mRNA | CTD | PMID:30851411 | 2-naphthylamine | decreases expression | ISO | RGD:1317667 | 6480464 | 2-Naphthylamine results in decreased expression of BTF3 mRNA | CTD | PMID:18247414 | 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole | affects expression | EXP | | 6480464 | Omeprazole affects the expression of BTF3 mRNA | CTD | PMID:19483382 | 6-propyl-2-thiouracil | affects expression | EXP | | 6480464 | Propylthiouracil affects the expression of BTF3 mRNA | CTD | PMID:19483382 | aconitine | decreases expression | EXP | | 6480464 | Aconitine results in decreased expression of BTF3 protein | CTD | PMID:33236894 | all-trans-retinoic acid | affects expression | ISO | RGD:1317667 | 6480464 | Tretinoin affects the expression of BTF3 mRNA | CTD | PMID:15498508 | all-trans-retinoic acid | decreases expression | ISO | RGD:1317667 | 6480464 | Tretinoin results in decreased expression of BTF3 mRNA | CTD | PMID:33167477 | amiodarone | affects expression | EXP | | 6480464 | Amiodarone affects the expression of BTF3 mRNA | CTD | PMID:19483382 | antimonite | multiple interactions | ISO | RGD:1317667 | 6480464 | [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of BTF3 mRNA | CTD | PMID:32076005 | antirheumatic drug | increases expression | ISO | RGD:1317667 | 6480464 | Antirheumatic Agents results in increased expression of BTF3 mRNA | CTD | PMID:24449571 | aristolochic acid | decreases expression | ISO | RGD:1317667 | 6480464 | aristolochic acid I results in decreased expression of BTF3 protein | CTD | PMID:33212167 | arsenite(3-) | multiple interactions | ISO | RGD:1317667 | 6480464 | [sodium arsenite results in increased abundance of arsenite] which results in decreased expression of BTF3 mRNA, arsenite promotes the reaction [G3BP1 protein binds to BTF3 mRNA] | CTD | PMID:32076005, PMID:32406909 | arsenous acid | increases expression | ISO | RGD:1317667 | 6480464 | Arsenic Trioxide results in increased expression of BTF3 mRNA | CTD | PMID:20458559 | benzbromarone | affects expression | EXP | | 6480464 | Benzbromarone affects the expression of BTF3 mRNA | CTD | PMID:19483382 | benzo[a]pyrene | decreases expression | ISO | RGD:1317667 | 6480464 | Benzo(a)pyrene results in decreased expression of BTF3 mRNA | CTD | PMID:18247414 | benzo[a]pyrene | increases expression | ISO | RGD:1317668 | 6480464 | Benzo(a)pyrene results in increased expression of BTF3 mRNA | CTD | PMID:22228805 | bisphenol A | decreases expression | ISO | RGD:1317668 | 6480464 | bisphenol A results in decreased expression of BTF3 mRNA | CTD | PMID:33221593 | cadmium atom | decreases expression | ISO | RGD:1317667 | 6480464 | Cadmium results in decreased expression of BTF3 mRNA | CTD | PMID:23369406 | carbon nanotube | increases expression | ISO | RGD:1317668 | 6480464 | Nanotubes, Carbon results in increased expression of BTF3 mRNA | CTD | PMID:25554681 | casticin | decreases expression | ISO | RGD:1317668 | 6480464 | casticin results in decreased expression of BTF3 mRNA | CTD | PMID:28444820 | chloropicrin | decreases expression | ISO | RGD:1317667 | 6480464 | chloropicrin results in decreased expression of BTF3 mRNA | CTD | PMID:26352163 | chromium(6+) | affects expression | ISO | RGD:1317668 | 6480464 | chromium hexavalent ion affects the expression of BTF3 mRNA | CTD | PMID:28472532 | clofibrate | affects expression | EXP | | 6480464 | Clofibrate affects the expression of BTF3 mRNA | CTD | PMID:19483382 | clofibrate | multiple interactions | ISO | RGD:1317668 | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of BTF3 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of BTF3 mRNA] | CTD | PMID:17585979 | clofibric acid | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of BTF3 mRNA | CTD | PMID:17602206 | diallyl trisulfide | increases expression | ISO | RGD:1317667 | 6480464 | diallyl trisulfide results in increased expression of BTF3 protein | CTD | PMID:16344271 | diarsenic trioxide | increases expression | ISO | RGD:1317667 | 6480464 | Arsenic Trioxide results in increased expression of BTF3 mRNA | CTD | PMID:20458559 | dibutyl phthalate | decreases expression | ISO | RGD:1317668 | 6480464 | Dibutyl Phthalate results in decreased expression of BTF3 mRNA | CTD | PMID:21266533 | dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate | multiple interactions | ISO | RGD:1317667 | 6480464 | [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of BTF3 mRNA | CTD | PMID:32076005 | doxorubicin | increases expression | ISO | RGD:1317667 | 6480464 | Doxorubicin results in increased expression of BTF3 mRNA | CTD | PMID:29803840 | enzyme inhibitor | multiple interactions | ISO | RGD:1317667 | 6480464 | [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of BTF3 protein | CTD | PMID:23301498 | flutamide | increases expression | EXP | | 6480464 | Flutamide results in increased expression of BTF3 mRNA | CTD | PMID:24136188 | folic acid | multiple interactions | ISO | RGD:1317668 | 6480464 | [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of BTF3 mRNA | CTD | PMID:22206623 | genistein | increases expression | ISO | RGD:1317668 | 6480464 | Genistein results in increased expression of BTF3 mRNA | CTD | PMID:16169203 | geraniol | decreases expression | ISO | RGD:1317667 | 6480464 | geraniol results in decreased expression of BTF3 mRNA | CTD | PMID:27683099 | ivermectin | decreases expression | ISO | RGD:1317667 | 6480464 | Ivermectin results in decreased expression of BTF3 protein | CTD | PMID:32959892 | L-ethionine | affects expression | EXP | | 6480464 | Ethionine affects the expression of BTF3 mRNA | CTD | PMID:19483382 | N-methyl-4-phenylpyridinium | decreases expression | ISO | RGD:1317667 | 6480464 | 1-Methyl-4-phenylpyridinium results in decreased expression of BTF3 protein | CTD | PMID:24806433 | N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of BTF3 mRNA | CTD | PMID:17602206 | nefazodone | increases expression | EXP | | 6480464 | nefazodone results in increased expression of BTF3 mRNA | CTD | PMID:24136188 | nicotine | decreases expression | ISO | RGD:1317667 | 6480464 | Nicotine results in decreased expression of BTF3 mRNA | CTD | PMID:18247414 | omeprazole | affects expression | EXP | | 6480464 | Omeprazole affects the expression of BTF3 mRNA | CTD | PMID:19483382 | paracetamol | affects expression | ISO | RGD:1317668 | 6480464 | Acetaminophen affects the expression of BTF3 mRNA | CTD | PMID:17562736 | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of BTF3 mRNA | CTD | PMID:33387578 | paracetamol | multiple interactions | ISO | RGD:1317668 | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of BTF3 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of BTF3 mRNA] | CTD | PMID:17585979 | PhIP | increases expression | EXP | | 6480464 | 2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine results in increased expression of BTF3 mRNA | CTD | PMID:15215175 | pirinixic acid | affects expression | EXP | | 6480464 | pirinixic acid affects the expression of BTF3 mRNA | CTD | PMID:19483382 | pirinixic acid | increases expression | ISO | RGD:1317668 | 6480464 | pirinixic acid results in increased expression of BTF3 mRNA | CTD | PMID:23811191 | potassium chromate | increases expression | ISO | RGD:1317667 | 6480464 | potassium chromate(VI) results in increased expression of BTF3 mRNA | CTD | PMID:22079256 | potassium chromate | multiple interactions | ISO | RGD:1317667 | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of BTF3 mRNA | CTD | PMID:22079256 | pregnenolone 16alpha-carbonitrile | increases expression | ISO | RGD:1317668 | 6480464 | Pregnenolone Carbonitrile results in increased expression of BTF3 mRNA | CTD | PMID:28903501 | propiconazole | increases expression | ISO | RGD:1317668 | 6480464 | propiconazole results in increased expression of BTF3 mRNA | CTD | PMID:21278054 | quinoline | decreases expression | ISO | RGD:1317667 | 6480464 | quinoline analog results in decreased expression of BTF3 protein | CTD | PMID:18645022 | rac-lactic acid | increases expression | ISO | RGD:1317667 | 6480464 | Lactic Acid results in increased expression of BTF3 mRNA | CTD | PMID:30851411 | resveratrol | decreases expression | ISO | RGD:1317668 | 6480464 | resveratrol results in decreased expression of BTF3 protein | CTD | PMID:25505154 | rotenone | increases expression | EXP | | 6480464 | Rotenone results in increased expression of BTF3 mRNA | CTD | PMID:28374803 | sodium arsenite | multiple interactions | ISO | RGD:1317667 | 6480464 | [sodium arsenite results in increased abundance of arsenite] which results in decreased expression of BTF3 mRNA | CTD | PMID:32076005 | sodium arsenite | decreases expression | ISO | RGD:1317667 | 6480464 | sodium arsenite results in decreased expression of BTF3 protein | CTD | PMID:30528433 | sunitinib | decreases expression | ISO | RGD:1317667 | 6480464 | Sunitinib results in decreased expression of BTF3 mRNA | CTD | PMID:31533062 | tamibarotene | affects expression | ISO | RGD:1317667 | 6480464 | tamibarotene affects the expression of BTF3 mRNA | CTD | PMID:15498508 | tamoxifen | affects expression | ISO | RGD:1317667 | 6480464 | Tamoxifen affects the expression of BTF3 mRNA | CTD | PMID:14699072 | tert-butyl hydroperoxide | increases expression | ISO | RGD:1317667 | 6480464 | tert-Butylhydroperoxide results in increased expression of BTF3 mRNA | CTD | PMID:15336504 | thioacetamide | affects expression | EXP | | 6480464 | Thioacetamide affects the expression of BTF3 mRNA | CTD | PMID:19483382 | trichloroethene | decreases expression | ISO | RGD:1317668 | 6480464 | Trichloroethylene results in decreased expression of BTF3 mRNA | CTD | PMID:19448997 | uranium atom | affects expression | ISO | RGD:1317667 | 6480464 | Uranium affects the expression of BTF3 mRNA | CTD | PMID:15672453 | |